Literature DB >> 8803823

Acute overdose of intrathecal baclofen.

J Dressnandt, F X Weinzierl, T R Tölle, A Konstanzer, B Conrad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8803823     DOI： 10.1007/bf00900504

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Electrophysiological findings in a case of severe intrathecal baclofen overdose.

Authors:  M Kofler; L Saltuari; E Schmutzhard; K Berek; H Baumgartner; L Russegger; F Aichner
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-07

2.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.

Authors:  B ASHWORTH
Journal:  Practitioner       Date:  1964-04

3.  CSF baclofen levels after intrathecal administration in severe spasticity.

Authors:  B Sallerin-Caute; Y Lazorthes; B Monsarrat; J Cros; R Bastide
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature.

Authors:  E M Delhaas; J R Brouwers
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-07

5.  Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases.

Authors:  G Müller-Schwefe; R D Penn
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115
  5 in total
  3 in total

1.  Accidental intoxication with 60 mg intrathecal baclofen: survived.

Authors:  Benjamin Berger; Barbara Vienenkoetter; Mirjam Korporal; Andrea Rocco; Hans-Michael Meinck; Thorsten Steiner
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  The use of opioids in children receiving intrathecal baclofen therapy.

Authors:  Giuliana Rizzo; Leonardo Bussolin; Lorenzo Genitori; Anna Zicca; Andrea Messeri; Matteo Lenge; Flavio Giordano
Journal:  Childs Nerv Syst       Date:  2019-04-26       Impact factor: 1.475

Review 3.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.